Recent News

• 06.03.2026 - Moelis CEO Navid Mahmoodzadegan to Speak at the 2026 Morgan Stanley US Financials Conference
• 06.03.2026 - Moelis Relocates London Office to Marylebone
• 05.19.2026 - Moelis Expands its Global Chemicals Franchise with Appointment of Matt Knott as a Managing Director in London
• 04.29.2026 - Moelis & Company Reports First Quarter 2026 Financial Results
• 04.28.2026 - Moelis Hires Lillian Tsinikas to Expand Healthcare Services Group
• 04.08.2026 - Moelis & Company to Announce First Quarter 2026 Financial Results and Host a Conference Call on April 29, 2026

Recent Filings

• 05.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.30.2026 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 04.30.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 04.30.2026 - DEF 14A Other definitive proxy statements
• 04.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.30.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2026 - ARS Annual Report to Security Holders
• 04.29.2026 - EX-99.1 EX-99.1
• 04.29.2026 - 8-K Current report